Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Philipp Kiewe"'
Autor:
Katja Sockel, Anke Mütherig, Martina Crysandt, Mathias Hänel, Richard Noppeney, Kerstin Schaefer-Eckart, Martin Kaufmann, Christoph Röllig, Johannes Schetelig, Sven Zukunft, Frank Fiebig, Aristoteles Giagounidis, Sebastian Scholl, Andreas Lück, Kathrin Rieger, Katharina Götze, Thomas Geer, Philipp Kiewe, Carsten Müller-Tidow, Hubert Serve, Claudia Baldus, Ulrich Kaiser, Stefan Mahlmann, Burkhard Schmidt, Stefani Parmentier, Thomas Illmer, Ruth Seggewiß-Bernhardt, Alexander Kiani, Hartmut Linde, Heinz Dürk, Michael Kramer, Desiree Kunadt, Katharina Schmidt-Brücken, Jana Hase, Susann Helas, Jan Moritz Middeke, Malte von Bonin, Uta Oelschlaegel, Gerhard Ehninger, Christian Thiede, Martin Bornhauser, Uwe Platzbecker
Publikováno v:
HemaSphere, Vol 7, p e09759ad (2023)
Externí odkaz:
https://doaj.org/article/acd4818220c24cd7946a96fe0e80f14b
Autor:
Krischan Braitsch, Laura K. Schmalbrock, Paul Jung, Irmgard Bumeder, Philipp Kiewe, Judith S. Hecker, Mareike Verbeek, Jörg Westermann, Lars Bullinger, Ulrich Keller, Florian Bassermann, Jan Krönke, Katharina S. Götze, Kathrin Rieger
Publikováno v:
HemaSphere, Vol 6, Iss 9, p e759 (2022)
Externí odkaz:
https://doaj.org/article/666804ca465842959a4be489c2e94e0d
Autor:
Thomas Benter, Oliver Roehr, Lutz Moser, Philipp Kiewe, Leopold Hentschel, Ivan Platzek, Markus K. Schuler
Publikováno v:
Case Reports in Oncological Medicine, Vol 2019 (2019)
Chemoradiation is one of the therapeutic options in palliative treatment of locally advanced pancreatic adenocarcinoma, with a well-known safety profile. In this case report, we describe the treatment-related occurrence of an intrasplenic pancreatic
Externí odkaz:
https://doaj.org/article/2c7fdc48610a438a9f555d05e4b4aad5
Autor:
Katharina Goetze, Philipp Kiewe, Krischan Braitsch, Laura K. Schmalbrock, Jörg Westermann, Jan Krönke, Florian Bassermann, Lars Bullinger, Ulrich Keller, Kathrin Rieger, Paul Jung, Irmgard Bumeder
Publikováno v:
Blood. 138:1257-1257
Introduction Treatment with the BCL-2 inhibitor Venetoclax (VEN) in combination with hypomethylating agents (HMA) or low-dose cytarabine (LDAC) has shown encouraging results in patients with acute myeloid leukemia (AML). In contrast to the FDA, EMA a
Autor:
Xiaosha Zhang, Karin Mayer, Matthew L. Sherman, Abderrahmane Laadem, Uwe Platzbecker, Katharina Götze, Markus P. Radsak, Kenneth M. Attie, Thomas Wolff, Jörg Chromik, Philipp Kiewe, Aristoteles Giagounidis, Ulrich Germing
Publikováno v:
The Lancet Oncology. 18:1338-1347
Myelodysplastic syndromes are characterised by ineffective erythropoiesis. Luspatercept (ACE-536) is a novel fusion protein that blocks transforming growth factor beta (TGF β) superfamily inhibitors of erythropoiesis, giving rise to a promising new
Autor:
Carolyn Barron, Xiaosha Zhang, Ulrich Germing, Karin Mayer, Markus P. Radsak, Joseph G. Reynolds, Joerg Chromik, Uwe Platzbecker, Philipp Kiewe, Abderrahmane Laadem, Kenneth M. Attie, Katharina Götze, Thomas Wolff, Aristoteles Giagounidis
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S319-S320
Background: Luspatercept, a first-in-class erythroid maturation agent, has been investigated in patients with LR-MDS and ring sideroblasts (RS) (MEDALIST; Fenaux and Platzbecker NEJM 2020) and in an ongoing Phase 3 trial regardless of RS status (COMM
Autor:
Leopold Hentschel, Markus K. Schuler, Philipp Kiewe, Oliver Roehr, Thomas Benter, Ivan Platzek, Lutz Moser
Publikováno v:
Case Reports in Oncological Medicine
Case Reports in Oncological Medicine, Vol 2019 (2019)
Case Reports in Oncological Medicine, Vol 2019 (2019)
Chemoradiation is one of the therapeutic options in palliative treatment of locally advanced pancreatic adenocarcinoma, with a well-known safety profile. In this case report, we describe the treatment-related occurrence of an intrasplenic pancreatic
Autor:
Florian H. Heidel, Andreas Hochhaus, Carl C Crodel, M. Reiser, Regine Wunschel, Kathleen Jentsch-Ulrich, Siegfried W. Prenninger, Lutz Jacobasch, Philipp Kiewe, Jörg Lipke, Jens Kisro
Publikováno v:
Blood. 134:1672-1672
Treatment recommendations for cytoreductive treatment of patients with polycythemia vera (PV) are well established. However, the clinical use and limitation of phlebotomies remain a matter of current debate (Barbui et al, Leukemia, 32; Heidel et al,
Autor:
Regina Herbst, Florian Nolte, Gustavo B. Baretton, Ina-Maria Klut, Martin Bornhäuser, Leopold Hentschel, Martin Wermke, H. K. Al-Ali, Gerhard Ehninger, Christiane Jakob, Detelef Haase, Wolf K. Hofmann, Uwe Platzbecker, Claudia Schönefeldt, Claudia Schuster, Philipp Kiewe, Malte von Bonin, Ulrich Germing
Publikováno v:
British journal of haematology. 175(5)
Summary The mammalian-target of rapamycin (also termed mechanistic target of rapamycin, mTOR) pathway integrates various pro-proliferative and anti-apoptotic stimuli and is involved in regulatory T-cell (TREG) development. As these processes contribu
Autor:
Georg Hess, Philipp Kiewe, M. Zaiss, Christian Scholz, Christian Buske, Roland Repp, Johannes Atta, P La Rosée, Mathias Witzens-Harig, Martin Dreyling, Christiane Pott, H. Kirchner, Georg Lenz, U. Keller, Andreas Viardot, H. Pelz, M. Reiser
Publikováno v:
Annals of Hematology. 91:1765-1772
In most patients, mantle cell lymphoma (MCL) shows an aggressive clinical course with a continuous relapse pattern and a median survival of only 3-5 years. In the current study generation of the European MCL Network, the addition of high-dose Ara-C t